Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent or Progressive PCNSL
NCT00712062Phase 2Withdrawn
- Sponsor
- University of Florida
- Start
- Feb 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pemetrexed in primary central nervous system lymphoma (PCNSL), sponsored by University of Florida. Planned start Feb 2009; status: withdrawn.
02
Drugs
pemetrexed
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00712062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712062.